Bafna Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 17 shareholders own 93.32% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
87.9%	SRJR Lifesciences LLP	20,785,312	₹1.6b	0%	no data
1.35%	Monarch Networth Finserve, Asset Management Arm	318,254	₹24.9m	0%	100.0%
0.9%	Vishwas Jain	213,280	₹16.7m	0%	no data
0.47%	Sera Investments & Finance India Limited	111,237	₹8.7m	0%	no data
0.44%	Akira Pharma Private Limited	104,995	₹8.2m	0%	no data
0.42%	Anushree Shah	100,000	₹7.8m	0%	no data
0.42%	Vrushali Shah	100,000	₹7.8m	0%	no data
0.31%	Guttikonda Lakshmi	72,478	₹5.7m	0%	no data
0.28%	Lindajeet Ruprai	66,735	₹5.2m	0%	no data
0.23%	Nisha Mehta	55,062	₹4.3m	0%	no data
0.21%	Paras Bafna	50,049	₹3.9m	0%	no data
0.2%	Bansilal Mahaveer Bafna	48,353	₹3.8m	0%	no data
0.18%	M. Naveen Bafna	42,000	₹3.3m	0%	no data
0.009%	Investor Education and Protection Fund (IEPF)	2,137	₹167.3k	0%	no data
0.0084%	Amribai Bafna	1,989	₹155.8k	0%	no data
0.0078%	Sasikala Bafna	1,844	₹144.3k	0%	no data
0.0051%	S. Hemalatha	1,199	₹93.9k	0%	no data